Home General Biotechnology Drug Patent Expirations in November 2007

Drug Patent Expirations in November 2007

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in November 2007
*Drugs may be covered by more than one patent

TradenameApplicantGeneric NamePatent NumberPatent Expiration
ANDRODERMWatson Labstestosterone4,849,224NOV 12,2007
ANDRODERMWatson Labstestosterone4,983,395NOV 12,2007
AVITAMylan Bertektretinoin4,971,800NOV 20,2007
COMTANOrionentacapone4,963,590NOV 27,2007
ELOCONScheringmometasone furoate4,775,529NOV 21,2007
FLECTORInst Biochemdiclofenac epolamine4,948,805NOV 09,2007
MERIDIAAbbottsibutramine hydrochloride4,929,629NOV 29,2007
MYLOTARGWyeth Pharms Incgemtuzumab ozogamicin4,970,198NOV 30,2007
PROVIGILCephalonmodafinil4,927,855NOV 22,2007
STALEVO 100Orioncarbidopa; entacapone; levodopa4,963,590NOV 27,2007
STALEVO 150Orioncarbidopa; entacapone; levodopa4,963,590NOV 27,2007
STALEVO 50Orioncarbidopa; entacapone; levodopa4,963,590NOV 27,2007
TOPROL-XLAstrazenecametoprolol succinate4,927,640NOV 22,2007
TYLENOL (CAPLET)Mcneil Consacetaminophen4,968,509NOV 06,2007
URSO 250Axcan Scandipharmursodiol4,859,660NOV 19,2007
URSO FORTEAxcan Scandipharmursodiol4,859,660NOV 19,2007

Courtesy of DrugPatentWatch.com

NO COMMENTS

  1. cephalon PAID TO HAVE THIS PATENT EXTENDED. BEYOND EXPIRATION.I PAY $10.00 PLUS FOR ONE PILL, TAKE THREE A DAY, $30.00 DAILY. MODAFINAL, THE GENERIC, IS NOT AVAILABLE IN THE U.S. A GOVERNMENT “FOR THE PEOPLE” .A FARCE WHEN BIG DRUG MANUFACTURERS PAY TO CONTROL ITS PATENT EXPIRATION

Leave a Reply